Acceptability and characteristics of 124 human bioequivalence studies with active substances classified according to the Biopharmaceutic Classification System

Elena Ramirez Olga Laosa Pedro Guerra Blanca Duque Beatriz Mosquera Alberto M. Borobia Suhua H. Lei Antonio J. Carcas Jesus Frias

首页> 外文期刊>British Journal of Clinical Pharmacology >Acceptability and characteristics of 124 human bioequivalence studies with active substances classified according to the Biopharmaceutic Classification System

【24h】

Acceptability and characteristics of 124 human bioequivalence studies with active substances classified according to the Biopharmaceutic Classification System

机译：根据生物制药分类系统对124种人体生物等效性研究的活性物质的可接受性和特征

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT

机译：关于此主题的已知知识

著录项

来源
《British Journal of Clinical Pharmacology》 |2010年第5期|p.694-702|共9页
作者
Elena Ramirez Olga Laosa Pedro Guerra Blanca Duque Beatriz Mosquera Alberto M. Borobia Suhua H. Lei Antonio J. Carcas Jesus Frias;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词
bioequivalence studies; biopharmaceutics classification system;

机译：生物等效性研究;生物药物分类体系;
入库时间 2022-08-17 14:09:38

相似文献

外文文献
中文文献
专利

1. Acceptability and characteristics of 124 human bioequivalence studies with active substances classified according to the Biopharmaceutic Classification System. [J] . Ramirez E, Laosa O, Guerra P, British Journal of Clinical Pharmacology . 2010,第5期

机译：根据生物制药分类系统对124种人体生物等效性研究的活性物质的可接受性和特征。
2. Acceptability and characteristics of 124 human bioequivalence studies with active substances classified according to the Biopharmaceutic Classification System [J] . Elena Ramirez, Olga Laosa, Pedro Guerra, British journal of clinical pharmacology . 2010,第5期

机译：124例人生物等效性研究的可接受性和特征，与生物制药分类系统分类的活性物质
3. A perspective for biowaivers of human bioequivalence studies on the basis of the combination of the ratio of AUC to the dose and the biopharmaceutics classification system. [J] . Sakuma S, Tachiki H, Uchiyama H, Molecular pharmaceutics . 2011,第4期

机译：基于AUC与剂量之比和生物制药分类系统相结合的人类生物等效性研究的生物豁免的观点。
4. Determination of amoxicillin in human plasma by LC-MS/MS and its application to a bioequivalence study [C] . Satish G. Pingale, Madhukara. Badgujar, Kiran V. Mangaonkar, Proceedings of the world medical conference . 2010

机译：LC-MS / MS法测定人血浆中的阿莫西林及其在生物等效性研究中的应用
5. Human Factors Analysis and Classification System Interrater Reliability for Biopharmaceutical Manufacturing Investigations [D] . Cintron, Roberto. 2015

机译：人为因素分析和分类系统生物制药制造调查的信度
6. Acceptability and characteristics of 124 human bioequivalence studies with active substances classified according to the Biopharmaceutic Classification System [O] . Elena Ramirez, Olga Laosa, Pedro Guerra, 2010

机译：根据生物制药分类系统对124种人体生物等效性研究的活性物质的可接受性和特征
7. Acceptability and characteristics of 124 human bioequivalence studies with active substances classified according to the Biopharmaceutic Classification System [O] . Ramirez, Elena, Laosa, Olga, Guerra, Pedro, 2010

机译：根据生物制药分类系统对124种人体生物等效性研究的活性物质的可接受性和特征
8. Guidance for Industry. Waiver of In Vivo Bioavailability and BioequivalenceStudies for Immediate-Release Solid Oral Dosage Forms Based on a Biopharmaceutics Classification System [R] . 2000

机译：工业指南。基于生物药剂学分类系统，立即释放固体口服剂型的体内生物利用度和生物等效性研究的放弃

Acceptability and characteristics of 124 human bioequivalence studies with active substances classified according to the Biopharmaceutic Classification System

摘要

著录项

相似文献

相关主题

期刊订阅